Floatz logo

Metformin

Periapical Periodontitis, Chronic Nonsuppurative

Celalettin TopbaşSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Periapical Periodontitis, Chronic Nonsuppurative cohort.

Asset / SponsorPhaseRating
Calcium hydroxide
Ain Shams University
Phase 4BBB
Nanocalcium Hydroxide
Cukurova University
N/AD
CHLORHEXIDINE
Cukurova University
N/AD
N-Acetyl-L-Cysteine
Cukurova University
N/AD

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →